Cowgill landslip detour adds hours to family's care trips
Rafferty, who is 20 months old, has a rare muscular condition which means he is quadriplegic, has to be fed via a tube and has significant difficulties with his breathing.The family arranged to train a carer who lives in Ingleton, to make the school run and logistics easier, but the landslip hit two weeks after the carer had qualified.
The detour is not just costing the family about £300 more in fuel each month, but is also potentially dangerous for Rafferty, they say."With somebody with complex needs as our boy Rafferty, it's really difficult to transport him around," Mr Strange, 40, said."One of the problems he has is that he vomits and then he's unable to clear his own airways, so we have to suction his airways or tip him upside down, and when we transport him in the car, that's much harder."He said much of the caring and driving to appointments was done by Mrs Strange, 39, who also juggles looking after their other two children - Wallace, four, and Dilys, two.
Mr Strange, who works as a paramedic, has set up a campaign group which is pressing Westmorland and Furness Council to find a solution.Earlier this week, he travelled with his wife and Rafferty to Parliament with a delegation from charity Hospice UK.The organisation lobbies government for policy change and represent hospices across the UK, including Jigsaw, a children's hospice based in Carlisle which supports the family.Mr Strange spoke to a group of MPs as part of the launch of a report called Bringing Care Closer to Home, which highlights inequalities that exist in rural communities for those who are dying or life-limited, such as lack of transport and the need to provide care at a distance.He said he felt listened to by the MPs and the report was due to be considered as part of the government's 10-year NHS plan."We were asked to go down partly because of the landslip, but also because of our experience with having a boy who is under the palliative care service, about the difficulties of living rurally," Mr Strange said.He said the couple chose to raise their children in the countryside "in pursuit of a simple and innocent life," but until he was faced with the challenges of accessing care for Rafferty, he had not appreciated the inequalities faced by families in rural areas.
Rafferty receives specialist care at Alder Hey Children's Hospital in Liverpool, as well as at hospitals in Lancaster and Kendal."It's a hard life for us now," Mr Strange said."Rafferty is a gorgeous happy little boy, it's just the situation we're in."The family, together with the community group they set up, are calling for Westmorland and Furness Council to create a temporary route through the diversion, while they continue to find a permanent solution to reopen the road.Mr Strange said: "We don't want to be in a position in the winter, where we're having to take our profoundly disabled boy over the hills, which are almost inaccessible, and then he has difficulties with his airways. "That is a genuinely life-threatening emergency that, short of us staying at home for the whole winter, I can't avoid."Westmorland and Furness Council said it was required to follow legal procedures to deliver a long-term solution and they were aware of the frustration the diversion had caused.It added the council was working with a contractor to actively develop "a proposed scheme" and was "preparing to carry out the necessary works to reopen the route, which is a top priority for the council".
Follow BBC Cumbria on X, Facebook, Nextdoor and Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
5 hours ago
- BBC News
'Missed opportunities' to save disabled girl found dead with mum
A disabled teenage girl could have been saved if an ambulance had attended her dying mother's 999 call - months before they were both found dead in their home, a coroner has Coroner's Court heard Alphonsine Djiako Leuga, 47, and 18-year-old Loraine Choulla had been dead for some time before they were found on 21 May 2024 in a house in was believed Alphonsine died first, in February, while Loraine - who had Down's syndrome and depended "entirely" on her mum - died of malnutrition and dehydration weeks later. On Friday, assistant coroner Amanda Bewley said authorities "missed opportunities" to escalate concerns around the pair. An inquest into their deaths, which started on Monday, heard Alphonsine had called for an ambulance on 2 February saying she was cold and could not move, but nobody attended.
Telegraph
2 days ago
- Telegraph
Labour urged to make it harder to sack sick staff
Labour has been urged to make it harder to sack sick workers in a bid to stop disabled staff from leaving the workforce. The Resolution Foundation - which was until last year headed by pensions minister Torsten Bell - has called on the Government to implement a raft of new rules including a 'right to reintegration' for staff on sick leave. Louise Murphy, economist at the think tank, said extra rights for disabled workers similar to those given to new mothers could transform employment prospects. 'The Government should do more to incentivise firms to employ disabled people, especially those who have been out of work for long periods. But employers need to do more in return,' she said. 'A new right to reintegration could help disabled workers back into work in the same way that maternity rights transformed women's employment prospects a generation ago.' The report said that rising levels of poor health means the Government has little chance of boosting employment to its 80pc target unless it takes steps to boost hiring of disabled workers.
Scottish Sun
3 days ago
- Scottish Sun
Ozempic-like fat jabs are BETTER than common drug at reducing dementia risk, study finds
Plus, all the ways you can lower your dementia risk if you have type 2 diabetes WIN WIN Ozempic-like fat jabs are BETTER than common drug at reducing dementia risk, study finds Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, say scientists. While both medications demonstrate neuroprotective properties, no comparison has been made up until now. Sign up for Scottish Sun newsletter Sign up 1 GLP-1 receptor agonists have recently gained popularity as a weight loss medication Credit: Getty Metformin is generally the first-line medication for type 2 diabetes, while GLP-1 receptor agonists are often used as second-line or add-on therapy when metformin is not sufficient or tolerated. In recent times, GLP-1 receptor agonists have gained popularity as a weight loss medication due to their ability to suppress appetite and promote feelings of fullness. Previously published research indicated people with type 2 diabetes have a significantly increased risk of developing dementia, with some studies reporting a 70 per cent higher risk compared to those without diabetes. And both GLP-1 receptor agonists and metformin have been shown to protect the brains of people with type 2 diabetes. But in the largest study of its kind, published in BMJ Open Diabetes Research & Care, GLP-1 receptor agonists were found to trump metformin when it comes to dementia risk. Researchers analysed health records from the period 2004 to 2024 to track the development of dementia in patients with type 2 diabetes who were treated with either GLP-1 receptor agonists or metformin for at least six consecutive months. While there was no significant difference in vascular dementia risk between the two types of drug, GLP-1 receptor agonist use was associated with a significantly lower risk of developing dementia, overall. Specifically, taking GLP-1 receptor agonists was linked to a lower risk of developing Alzheimer's disease, and a 25 per cent lower risk of developing non-vascular dementias than metformin use. These positive effects were evident across all age groups, but with the strongest effect among the over 60s, women, and those of white ethnicity. Risk of death from any cause was also found to be lower - nearly 5 per cent of those treated with GLP-1 receptor agonists died compared with nearly 9 per cent of those treated with metformin. The 14 science-backed ways to prevent dementia 'Both medications demonstrate neuroprotective properties, such as reducing neuroinflammation and oxidative stress, improving insulin sensitivity, and enhancing cerebrovascular health, which likely contribute to their benefits in overall dementia,' explain the researchers. But unlike metformin, GLP-1 receptor agonists exert direct central nervous system effects by crossing the blood-brain barrier, they add. The researchers point out their tracking period, while sufficient for observing dementia outcomes, may not fully capture long-term cognitive effects, especially given the progressive nature of Alzheimer's disease. But they conclude: "Given the severe societal, familial , and economic burden of diabetes-related dementia, these findings raise important considerations about the tole of GLP-1 [receptor agonists] as first-line therapies in [type 2 diabetes] management. "While further long-term studies are warranted to validate these results, integrating GLP-1 [receptor agonists] as primary therapeutic agents may represent a paradigm shift in preventing the cognitive complications of diabetes.' All GLP-1 medicines are prescription only medicines, which means they can only be prescribed by a healthcare professional. GLP-1 medicines can also be purchased privately. If you want to get a GLP-1 medicine privately, a consultation with a healthcare professional must happen before the prescription can be issued, so the prescriber can carry out proper checks and make sure you are aware of the benefits and risks of taking the medicine. GLP-1 medicines should not be bought from unregulated sellers such as beauty salons or via social media, or from anywhere without a prior consultation with a healthcare professional. The Medicines & Healthcare products Regulatory Agency (MHRA) has had reports of people experiencing severe side effects from fake GLP-1 medicines.
